"Breast Density" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurement of relative composition of different BREAST tissue types often determined from MAMMOGRAPHY; ULTRASONOGRAPHY; or MRI.
Descriptor ID |
D000071060
|
MeSH Number(s) |
E01.370.600.115.275 G07.100.138
|
Concept/Terms |
Mammographic Breast Density- Mammographic Breast Density
- Breast Densities, Mammographic
- Breast Density, Mammographic
- Mammographic Breast Densities
- Mammographic Density
- Density, Mammographic
- Mammographic Densities
|
Below are MeSH descriptors whose meaning is more general than "Breast Density".
Below are MeSH descriptors whose meaning is more specific than "Breast Density".
This graph shows the total number of publications written about "Breast Density" by people in this website by year, and whether "Breast Density" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 0 | 1 | 1 |
2018 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Breast Density" by people in Profiles.
-
A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Eur J Cancer. 2018 11; 104:39-46.
-
Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study. Breast Cancer Res. 2018 08 09; 20(1):95.
-
The role of matricellular proteins and tissue stiffness in breast cancer: a systematic review. Future Oncol. 2018 Jul; 14(16):1601-1627.
-
Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study. Breast Cancer Res. 2018 06 05; 20(1):46.
-
Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer. J Epidemiol. 2017 Mar; 27(3):98-106.